Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction

Steg, 2012, ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Eur Heart J, 33, 2569, 10.1093/eurheartj/ehs215 Montalescot, 2013, 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the Management of Stable Coronary Artery Disease of the European Society of Cardiology, Eur Heart J, 34, 2949, 10.1093/eurheartj/eht296 1998, Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials, Circulation, 97, 2202, 10.1161/01.CIR.97.22.2202 1993, Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure, Lancet, 342, 821 Kober, 1995, A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction, N Engl J Med, 333, 1670, 10.1056/NEJM199512213332503 Pfeffer, 1992, Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction, N Engl J Med, 327, 669, 10.1056/NEJM199209033271001 Dickstein, 2002, Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial, Lancet, 360, 752, 10.1016/S0140-6736(02)09895-1 Pfeffer, 2003, Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both, N Engl J Med, 349, 1893, 10.1056/NEJMoa032292 Amsterdam, 2014, 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 64, e139, 10.1016/j.jacc.2014.09.017 Go, 2004, Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization, N Engl J Med, 351, 1296, 10.1056/NEJMoa041031 Astor, 2011, Association of estimated glomerular filtration rate and albuminuria with mortality and end-stage renal disease: a collaborative meta-analysis of kidney disease cohorts, Kidney Int, 79, 1331, 10.1038/ki.2010.550 Szummer, 2010, Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the SWEDEHEART register, J Intern Med, 268, 40 Szummer, 2009, Circulation, 120, 851, 10.1161/CIRCULATIONAHA.108.838169 Fox, 2003, Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study), Lancet, 362, 782, 10.1016/S0140-6736(03)14286-9 Yusuf, 2000, Effects of an angiotensin-converting–enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients, N Engl J Med, 342, 145, 10.1056/NEJM200001203420301 Molnar, 2013, ACE inhibitor and angiotensin receptor blocker use and mortality in patients with chronic kidney disease, J Am Coll Cardiol, 63, 659 Jernberg, 2010, The SwedishWeb-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART), Heart, 96, 1617, 10.1136/hrt.2010.198804 Wettermark, 2013, The Nordic prescription databases as a resource for pharmacoepidemiological research—a literature review, Pharmacoepidemiol Drug Saf, 22, 691, 10.1002/pds.3457 Levey, 2009, A new equation to estimate glomerular filtration rate, Ann Intern Med, 150, 604, 10.7326/0003-4819-150-9-200905050-00006 Levey, 2007, Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values, Clin Chem, 53, 766, 10.1373/clinchem.2006.077180 2013, Summary of recommendation statements, Kidney Int Suppl (2011), 3, 5, 10.1038/kisup.2012.77 Swedish Renal Registry. Swedish Renal Registry: annual report. Available at: http://www.snronline.se. Accessed June 15, 2015. Dagenais, 2006, Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials, Lancet, 368, 581, 10.1016/S0140-6736(06)69201-5 Danchin, 2006, Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials, Arch Intern Med, 166, 787, 10.1001/archinte.166.7.787 Braunwald, 2004, Angiotensin converting enzyme inhibition for stable coronary artery disease, N Engl J Med, 35, 2058 Amann, 2014, Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry), Am J Cardiol, 114, 329, 10.1016/j.amjcard.2014.04.046 Gunnell, 2013, Improved long-term survival in patients on combination therapies following an incident acute myocardial infarction: a longitudinal population-based study, Heart, 99, 1353, 10.1136/heartjnl-2013-304348 Hara, 2014, Comparison of 5-year survival after acute myocardial infarction using angiotensin-converting enzyme inhibitor versus angiotensin ii receptor blocker, Am J Cardiol, 114, 1, 10.1016/j.amjcard.2014.03.055 Ruggenenti, 1998, Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial, Lancet, 352, 1252, 10.1016/S0140-6736(98)04433-X Remuzzi, 2004, Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoc analysis of the RENAAL trial results, J Am Soc Nephrol, 15, 3117, 10.1097/01.ASN.0000146423.71226.0C